Amyloid-ß-directed immunotherapy for Alzheimer's disease

Lannfelt L, Relkin NR, Siemers ER (Uppsala University, Uppsala, Sweden; Weill Cornell Medical College, New York, NY; and Eli Lilly and Co., Indianapolis, IN, USA). Amyloid-ß-directed immunotherapy for Alzheimer’s disease. (Key Symposium). J Intern Med 2014; 275: 284–295. Current treatment options fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lannfelt, L, Relkin, N R, Siemers, E R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Key Symposium: Updating Alzheimer's Disease Diagnosis - Implications for Prevention and Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238820/
https://www.ncbi.nlm.nih.gov/pubmed/24605809
http://dx.doi.org/10.1111/joim.12168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238820/
https://www.ncbi.nlm.nih.gov/pubmed/24605809
http://dx.doi.org/10.1111/joim.12168

Ejemplares similares